Contacts: | Veronica Garza Investor Relations (512) 683-6873 |
National Instruments Reports Record Quarterly Revenue of $215M, Up 17 percent Year over Year
Company Reports Strong Cash Flow and $276 Million in Cash and Short-Term Investments
AUSTIN, Texas – Oct. 28, 2008 –National Instruments (Nasdaq: NATI) reported record quarterly revenue of $215 million, up 17 percent year-over-year, in the third quarter of 2008. This was above the midpoint of NI’s guidance of between $208 million and $218 million.
Net income for Q3 2008 was $23.2 million, up 7.5 percent from Q3 last year, representing diluted earnings per share (EPS) of $0.29. Non-GAAP net income was $27.7 million, up 7.4 percent from Q3 last year, with fully diluted EPS of $0.35, which was at the midpoint of NI’s guidance. Included in both GAAP and non-GAAP earnings for Q3 is a net loss on foreign exchange of $3 million, or $0.03 per share, as a result of the dramatic strengthening of the U.S. dollar in Q3. The company had not anticipated this loss when giving guidance in July. The company’s non-GAAP results exclude the impact of both stock-based compensation and the amortization of acquisition-related intangibles. Reconciliations of the company’s GAAP and non-GAAP results are included as part of this news release.
“I am very pleased with our 17 percent revenue growth in the face of significant economic headwinds, driven by record revenue in PXI, NI CompactRIO, modular instruments, machine vision and motion control,” said Dr. James Truchard, NI president and CEO. “There is no doubt that the current global economic situation presents challenges, but I believe our business model is strong, our investments are wise and our long-term strategy is sound.”
NI virtual instrumentation and graphical system design products, which represent more than 90 percent of the company’s product portfolio, had 19 percent year-over-year revenue growth in Q3 2008. The revenue growth of these products relative to the global PMI improved in Q3 and has been steadily improving over the last eight quarters. This validates the company’s strategy of strong investment in R&D and field sales force expansion to drive new product success.
“Given the current uncertainty, our strategy going forward is to be very realistic about the economy but also to continue to drive market share gains,” said Alex Davern, NI CFO. “We will manage our expenses carefully by focusing our investments on R&D and the field sales expansion while significantly limiting expense growth in other areas of the company.”
For the first nine months of 2008, the company reported record revenue of $618.4 million, up 15.5 percent as compared to the first nine months of 2007. Geographically, revenue in U.S. dollar terms for Q3 2008 compared to Q3 2007 was up 12 percent in the Americas, up 28 percent in Europe and up 11 percent in Asia, equaling overall growth of 17 percent. In local currency terms, revenue was up 12 percent in Europe and 7 percent in Asia.
National Instruments Reports Record Quarterly Revenue
Oct. 28, 2008
Page 2
As of Sept. 30, 2008, the company had $276 million in net cash and short-term investments, up $28 million from June 30, 2008. During the quarter, the company used $9 million for the payment of dividends. The NI Board of Directors declared a dividend of $0.11 per share on its common stock payable on Dec. 1, 2008, to shareholders of record on Nov. 10, 2008.
Q3 2008 Highlights
· | Record quarterly revenue of $215 million, up 17 percent year-over-year |
· | Net income of $23.2 million, up 7.5 percent year-over-year |
· | Non-GAAP net income of $27.7 million, up 7.4 percent year-over-year |
· | Record revenue for PXI, NI CompactRIO, modular instruments, machine vision, and motion control |
· | Cash and short-term investments of $276 million |
· | New product releases, including NI LabVIEW 8.6 software, PXI Express 6.6 GHz RF instruments, Wi-Fi and Ethernet data acquisition hardware and NI Single-Board RIO devices |
· | Record attendance at NIWeek 2008 |
Guidance for Q4 2008
For Q4, NI currently expects revenue to be in the range of $208 million to $222 million. This is equivalent to year-over-year revenue growth of between 2 percent and 8 percent. The year-over-year growth in total operating expenses in Q4 is expected to be between 3 percent and 6 percent, down from 18 percent year-over-year growth in the first nine months of 2008. The company currently expects that GAAP fully diluted EPS will be in the range of $0.33 to $0.41 per share for Q4, with non-GAAP fully diluted EPS expected to be in the range of $0.39 to $0.47 per share.
When comparing the company’s guidance with NI GAAP and non-GAAP fully diluted EPS in Q4 2007 of $0.56 and $0.62, respectively, note that in Q4 last year, NI recognized an $18 million tax credit, which had the impact of increasing NI GAAP and non-GAAP EPS by $0.23.
In Q4 2008, the company expects the impact of stock-based compensation and the impact of the amortization of acquisition-related intangibles to be $0.06 per share. A reconciliation of the company’s Q4 2008 guidance on a GAAP basis to its guidance on a non-GAAP basis is included as part of this news release.
Because the direction of the financial markets is uncertain and its impact on the broad-based industrial economy is difficult to currently predict, National Instruments will hold a business update call on Dec. 4 at 4.00 p.m. CST.
National Instruments Reports Record Quarterly Revenue
Oct. 28, 2008
Page 3
Non-GAAP Earnings Presentation and Non-GAAP Earnings Guidance
In addition to disclosing results determined in accordance with GAAP, NI discloses certain non-GAAP operating results that exclude certain charges. In this news release, the company has presented its gross profit, operating margin, net income and diluted EPS results for Q3 2008 and Q3 2007 and its guidance for Q4 2008, in each case on a GAAP and non-GAAP basis. When presenting non-GAAP results, the company includes a reconciliation of the non-GAAP results to the results under GAAP.
Management also considers such non-GAAP results to be an important supplemental measure of its performance. The economic substance behind management’s decision to use such non-GAAP measures relates to these charges being non-cash in nature and being a useful measure of the potential future performance of the company’s business.
In line with common industry practice and to help enable comparability with other technology companies, the company’s non-GAAP presentation excludes the impact of both stock-based compensation and the amortization of acquisition-related intangibles. Other companies may calculate non-GAAP results differently than NI, limiting the calculation’s usefulness as a comparative measure. In addition, such non-GAAP measures may exclude financial information that some may consider important in evaluating the company’s performance. Management compensates for the foregoing limitations of non-GAAP measures by presenting certain information on both a GAAP and non-GAAP basis and providing reconciliations of these certain GAAP and non-GAAP measures.
Conference Call Information
Interested parties can listen to a conference call today, Oct. 28, beginning at 4:00 p.m. CDT, at www.ni.com/call. Replay information is available by calling (888) 203-1112, confirmation code #4212906, from Oct. 28 at 7:00 p.m. CDT through Nov. 5 at midnight CDT.
Forward-Looking Statements
This release contains “forward-looking statements,” including statements related to record revenue in Q4 and for the full year 2008; business model being strong, investments wise and long-term strategy sound; strategy of R&D investment and field sales expansion driving new product success; likely contraction of test and measurement market; commitment to investments in R&D and field sales force to drive revenue growth; plan to moderate expense growth; and NI guidance for Q4 2008, including, as applicable, revenue, GAAP and non-GAAP diluted EPS, the estimated impact of stock-based compensation and acquisition-related intangibles. These statements are subject to a number of risks and uncertainties, including the risk of further adverse changes or fluctuations in the global economy as a result of recent challenges the global credit and equity markets face, delays in the release of new products, fluctuations in customer demand for NI products, manufacturing inefficiencies and foreign exchange fluctuations. Actual results may differ materially from the
National Instruments Reports Record Quarterly Revenue
Oct. 28, 2008
Page 4
expected results. The company directs readers to documents it files with the SEC for other risks associated with the company’s future performance.
About National Instruments
National Instruments (www.ni.com) is transforming the way engineers and scientists design, prototype and deploy systems for measurement, automation and embedded applications. NI empowers customers with off-the-shelf software such as NI LabVIEW and modular cost-effective hardware, and sells to a broad base of more than 25,000 different companies worldwide, with no one customer representing more than 3 percent of revenue and no one industry representing more than 10 percent of revenue. Headquartered in Austin, Texas, NI has more than 5,000 employees and direct operations in nearly 40 countries. For the past nine years, FORTUNE magazine has named NI one of the 100 best companies to work for in America. Readers can obtain investment information from the company’s investor relations department by calling (512) 683-5090, e-mailing nati@ni.com or visiting www.ni.com/nati.
CompactRIO, LabVIEW, National Instruments, NI, ni.com and NIWeek are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.
National Instruments Reports Record Quarterly Revenue
Oct. 28, 2008
Page 5
National Instruments
Condensed Consolidated Balance Sheets
(in thousands)
| | September 30, | | | December 31, | |
| | 2008 | | | 2007 | |
| | (unaudited) | | | | |
Assets | | | | | | |
Current assets: | | | | | | |
Cash and cash equivalents | | | 213,665 | | | | 194,839 | |
Short-term investments | | | 61,919 | | | | 93,838 | |
Accounts receivable, net | | | 123,096 | | | | 131,282 | |
Inventories, net | | | 99,734 | | | | 82,675 | |
Prepaid expenses and other current assets | | | 40,377 | | | | 23,312 | |
Deferred income taxes, net | | | 20,459 | | | | 19,264 | |
Total current assets | | | 559,250 | | | | 545,210 | |
| | | | | | | | |
Long-term investments | | | 10,154 | | | | - | |
Property and equipment, net | | | 155,251 | | | | 151,462 | |
Goodwill, net | | | 64,641 | | | | 54,111 | |
Intangible assets, net | | | 44,844 | | | | 40,357 | |
Other long-term assets | | | 28,168 | | | | 27,672 | |
Total assets | | | 862,308 | | | | 818,812 | |
| | | | | | | | |
Liabilities and Stockholders' Equity | | | | | | | | |
Current liabilities: | | | | | | | | |
Accounts payable | | | 31,733 | | | | 36,187 | |
Accrued compensation | | | 31,003 | | | | 25,778 | |
Deferred revenue | | | 42,076 | | | | 36,091 | |
Accrued expenses and other liabilities | | | 10,320 | | | | 10,437 | |
Other taxes payable | | | 23,379 | | | | 16,843 | |
Total current liabilities | | | 138,511 | | | | 125,336 | |
| | | | | | | | |
Deferred income taxes | | | 24,022 | | | | 21,221 | |
Other long-term liabilities | | | 11,500 | | | | 11,169 | |
Total liabilities | | | 174,033 | | | | 157,726 | |
| | | | | | | | |
Stockholders' equity: | | | | | | | | |
Preferred stock | | | - | | | | - | |
Common stock | | | 790 | | | | 794 | |
Additional paid-in capital | | | 75,231 | | | | 89,809 | |
Retained earnings | | | 602,872 | | | | 563,418 | |
Accumulated other comprehensive income | | | 9,382 | | | | 7,065 | |
Total stockholders' equity | | | 688,275 | | | | 661,086 | |
Total liabilities and stockholders' equity | | | 862,308 | | | | 818,812 | |
National Instruments Reports Record Quarterly Revenue
Oct. 28, 2008
Page 6
National Instruments
Condensed Consolidated Statements of Income
(in thousands, except per share data)
(unaudited)
| | Three Months Ended | | | Nine Months Ended | |
| | September 30, | | | September 30, | |
| | | | | | |
| | 2008 | | | 2007 | | | 2008 | | | 2007 | |
| | | | | | | | | | | | |
Net sales | | $ | 215,038 | | | $ | 184,426 | | | $ | 618,430 | | | $ | 535,565 | |
Cost of sales | | | 53,537 | | | | 46,219 | | | | 154,227 | | | | 132,439 | |
Gross profit | | | 161,501 | | | | 138,207 | | | | 464,203 | | | | 403,126 | |
| | | | | | | | | | | | | | | | |
Operating expenses: | | | | | | | | | | | | | | | | |
Sales and marketing | | | 79,362 | | | | 66,116 | | | | 233,427 | | | | 194,974 | |
Research and development | | | 37,016 | | | | 31,891 | | | | 105,808 | | | | 91,652 | |
General and administrative | | | 17,177 | | | | 15,644 | | | | 51,122 | | | | 45,643 | |
| | | | | | | | | | | | | | | | |
Total operating expenses | | | 133,555 | | | | 113,651 | | | | 390,357 | | | | 332,269 | |
| | | | | | | | | | | | | | | | |
Operating income | | | 27,946 | | | | 24,556 | | | | 73,846 | | | | 70,857 | |
| | | | | | | | | | | | | | | | |
Interest income | | | 1,374 | | | | 2,613 | | | | 5,025 | | | | 7,056 | |
Net foreign exchange gain (loss) | | | (3,025 | ) | | | 98 | | | | (1,791 | ) | | | 628 | |
Other income (expense), net | | | 80 | | | | 14 | | | | 13 | | | | (138 | ) |
| | | | | | | | | | | | | | | | |
Income before income taxes | | | 26,375 | | | | 27,281 | | | | 77,093 | | | | 78,403 | |
| | | | | | | | | | | | | | | | |
Provision for income taxes | | | 3,216 | | | | 5,741 | | | | 11,584 | | | | 17,063 | |
| | | | | | | | | | | | | | | | |
Net income | | $ | 23,159 | | | $ | 21,540 | | | $ | 65,509 | | | $ | 61,340 | |
| | | | | | | | | | | | | | | | |
Basic earnings per share | | $ | 0.29 | | | $ | 0.27 | | | $ | 0.83 | | | $ | 0.77 | |
Diluted earnings per share | | $ | 0.29 | | | $ | 0.27 | | | $ | 0.82 | | | $ | 0.76 | |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding - | | | | | | | | | | | | | | | | |
basic | | | 78,834 | | | | 79,226 | | | | 78,701 | | | | 79,471 | |
diluted | | | 79,841 | | | | 80,874 | | | | 79,773 | | | | 80,986 | |
| | | | | | | | | | | | | | | | |
Dividends declared per share | | $ | 0.11 | | | $ | 0.10 | | | $ | 0.33 | | | $ | 0.24 | |
National Instruments Reports Record Quarterly Revenue
Oct. 28, 2008
Page 7
National Instruments
Condensed Consolidated Statements of Cash Flows
(in thousands)
| | Nine Months Ended | |
| | September 30, | | | September 30, | |
| | 2008 | | | 2007 | |
| | (unaudited) | | | (unaudited) | |
Cash flow from operating activities: | | | | | | |
Net income | | $ | 65,509 | | | $ | 61,340 | |
Adjustments to reconcile net income to net cash provided | | | | | | | | |
by operating activities: | | | | | | | | |
Depreciation and amortization | | | 27,901 | | | | 27,964 | |
Stock-based compensation | | | 14,690 | | | | 13,051 | |
Provision for (benefit from) deferred income taxes | | | 3,008 | | | | (360 | ) |
Tax benefit from stock option plans | | | (1,243 | ) | | | (2,391 | ) |
Changes in operating assets and liabilities: | | | | | | | | |
Accounts receivable | | | 10,611 | | | | (4,056 | ) |
Inventories | | | (16,954 | ) | | | (175 | ) |
Prepaid expenses and other assets | | | (12,895 | ) | | | (14,186 | ) |
Accounts payable | | | (4,791 | ) | | | 7,874 | |
Deferred revenue | | | 5,985 | | | | 7,774 | |
Taxes and other liabilities | | | 14,138 | | | | 16,797 | |
Net cash provided by operating activities | | | 105,959 | | | | 113,632 | |
| | | | | | | | |
Cash flow from investing activities: | | | | | | | | |
Capital expenditures | | | (21,115 | ) | | | (18,109 | ) |
Capitalization of internally developed software | | | (8,687 | ) | | | (7,736 | ) |
Additions to other intangibles | | | (2,603 | ) | | | (4,962 | ) |
Acquisition, net of cash received | | | (17,310 | ) | | | - | |
Purchases of short-term and long-term investments | | | (17,315 | ) | | | (62,968 | ) |
Sales and maturities of short-term and long-term investments | | | 39,080 | | | | 120,530 | |
Purchases of foreign currency option contracts | | | (2,784 | ) | | | - | |
Net cash provided by (used in) investing activities | | | (30,734 | ) | | | 26,755 | |
| | | | | | | | |
Cash flow from financing activities: | | | | | | | | |
Proceeds from issuance of common stock | | | 26,628 | | | | 27,454 | |
Repurchase of common stock | | | (58,215 | ) | | | (67,957 | ) |
Dividends paid | | | (26,055 | ) | | | (19,091 | ) |
Tax benefit from stock option plans | | | 1,243 | | | | 2,391 | |
Net cash provided by (used in) financing activities | | | (56,399 | ) | | | (57,203 | ) |
| | | | | | | | |
Net change in cash and cash equivalents | | | 18,826 | | | | 83,184 | |
Cash and cash equivalents at beginning of period | | | 194,839 | | | | 100,287 | |
Cash and cash equivalents at end of period | | $ | 213,665 | | | $ | 183,471 | |
National Instruments Reports Record Quarterly Revenue
October 28, 2008
Page 8
Detail of GAAP charges related to stock-based compensation and amortization of acquisition intangibles (unaudited) | | | | |
| | | | | | | | | | | | |
| | Three Months Ended | | | Nine Months Ended | |
| | September 30, | | | September 30, | |
| | | | | | | | | | | | |
| | 2008 | | | 2007 | | | 2008 | | | 2007 | |
Stock-based compensation | | | | | | | | | | | | |
Cost of sales | | $ | 295 | | | $ | 252 | | | $ | 810 | | | $ | 672 | |
Sales and marketing | | | 2,114 | | | | 1,932 | | | | 6,204 | | | | 5,347 | |
Research and development | | | 1,867 | | | | 1,719 | | | | 5,160 | | | | 4,673 | |
General and administrative | | | 800 | | | | 770 | | | | 2,351 | | | | 2,104 | |
Provision for income taxes | | | (1,364 | ) | | | (1,032 | ) | | | (3,588 | ) | | | (2,722 | ) |
Total | | $ | 3,712 | | | $ | 3,641 | | | $ | 10,937 | | | $ | 10,074 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Amortization of acquisition intangibles | | | | | | | | | | | | | | | | |
Cost of sales | | $ | 937 | | | $ | 678 | | | $ | 2,725 | | | $ | 2,033 | |
Sales and marketing | | | 139 | | | | 111 | | | | 435 | | | | 335 | |
Research and development | | | - | | | | 9 | | | | 14 | | | | 25 | |
General and administrative | | | - | | | | - | | | | - | | | | - | |
Provision for income taxes | | | (285 | ) | | | (217 | ) | | | (846 | ) | | | (688 | ) |
Total | | $ | 791 | | | $ | 581 | | | $ | 2,328 | | | $ | 1,705 | |
National Instruments Reports Record Quarterly Revenue
October 28, 2008
Page 9
National Instruments
Reconciliation of GAAP to Non-GAAP Measures
(in thousands, except per share data)
(unaudited)
Reconciliation of Gross Profit to Non-GAAP Gross Profit | | | | | | | |
| | | | | | | | | | | | |
| | Three Months Ended | | | Nine Months Ended | |
| | September 30, | | | September 30, | |
| | | | | | | | | | | | |
| | 2008 | | | 2007 | | | 2008 | | | 2007 | |
| | | | | | | | | | | | |
Gross profit, as reported | | $ | 161,501 | | | $ | 138,207 | | | $ | 464,203 | | | $ | 403,126 | |
Stock-based compensation | | | 295 | | | | 252 | | | | 810 | | | | 672 | |
Amortization of acquisition intangibles | | | 937 | | | | 678 | | | | 2,725 | | | | 2,033 | |
| | | | | | | | | | | | | | | | |
Non-GAAP gross profit | | $ | 162,733 | | | $ | 139,137 | | | $ | 467,738 | | | $ | 405,831 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Reconciliation of Operating Income to Non-GAAP Operating Income | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | | Nine Months Ended | |
| | September 30, | | | September 30, | |
| | | | | | | | | | | | | | | | |
| | 2008 | | | 2007 | | | 2008 | | | 2007 | |
| | | | | | | | | | | | | | | | |
Operating income, as reported | | $ | 27,946 | | | $ | 24,556 | | | $ | 73,846 | | | $ | 70,857 | |
Stock-based compensation | | | 5,076 | | | | 4,673 | | | | 14,525 | | | | 12,796 | |
Amortization of acquisition intangibles | | | 1,076 | | | | 798 | | | | 3,174 | | | | 2,393 | |
| | | | | | | | | | | | | | | | |
Non-GAAP operating income | | $ | 34,098 | | | $ | 30,027 | | | $ | 91,545 | | | $ | 86,046 | |
National Instruments Reports Record Quarterly Revenue
October 28, 2008
Page 10
Reconciliation of Income before income taxes to Non-GAAP Income before income taxes | | | | |
| | | | | | | | | | | | |
| | Three Months Ended | | | Nine Months Ended | |
| | September 30, | | | September 30, | |
| | | | | | | | | | | | |
| | 2008 | | | 2007 | | | 2008 | | | 2007 | |
| | | | | | | | | | | | |
Income before income taxes, as reported | | $ | 26,375 | | | $ | 27,281 | | | $ | 77,093 | | | $ | 78,403 | |
Stock-based compensation | | | 5,076 | | | | 4,673 | | | | 14,525 | | | | 12,796 | |
Amortization of acquisition intangibles | | | 1,076 | | | | 798 | | | | 3,174 | | | | 2,393 | |
| | | | | | | | | | | | | | | | |
Non-GAAP income before income taxes | | $ | 32,527 | | | $ | 32,752 | | | $ | 94,792 | | | $ | 93,592 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Reconciliation of Provision for Income Taxes to Non-GAAP Provision for Income Taxes | | | | | |
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | | Nine Months Ended | |
| | September 30, | | | September 30, | |
| | | | | | | | | | | | | | | | |
| | 2008 | | | 2007 | | | 2008 | | | 2007 | |
| | | | | | | | | | | | | | | | |
Provision for income taxes, as reported | | $ | 3,216 | | | $ | 5,741 | | | $ | 11,584 | | | $ | 17,063 | |
Stock-based compensation | | | 1,364 | | | | 1,032 | | | | 3,588 | | | | 2,722 | |
Amortization of acquisition intangibles | | | 285 | | | | 217 | | | | 846 | | | | 688 | |
| | | | | | | | | | | | | | | | |
Non-GAAP provision for income taxes | | $ | 4,865 | | | $ | 6,990 | | | $ | 16,018 | | | $ | 20,473 | |
National Instruments Reports Record Quarterly Revenue
October 2008
Page 11
Reconciliation of Net Income and Diluted EPS to Non-GAAP Net Income and Non-GAAP Diluted EPS | |
| | | | | |
| | Three Months Ended | Nine Months Ended |
| | September 30, | September 30, |
| | | | | |
| | 2008 | 2007 | 2008 | 2007 |
| | | | | |
Net income, as reported | | $ 23,159 | $ 21,540 | $ 65,509 | $ 61,340 |
Adjustments to reconcile net income to non-GAAP net income: | | | | |
Stock-based compensation, net of tax effect | | 3,712 | 3,641 | 10,937 | 10,074 |
Amortization of acquisition intangibles, net of tax effect | | 791 | 581 | 2,328 | 1,705 |
| | | | | |
Non-GAAP net income | | $ 27,662 | $ 25,762 | $ 78,774 | $ 73,119 |
| | | | | |
Basic EPS, as reported | | $ 0.29 | $ 0.27 | $ 0.83 | $ 0.77 |
Adjustment to reconcile basic EPS to non-GAAP | | | | | |
basic EPS: | | | | | |
Impact of stock-based compensation, net of tax effect | | $ 0.05 | $ 0.05 | $ 0.14 | $ 0.13 |
Impact of amortization of acquisition intangibles, net of tax effect | $ 0.01 | $ 0.01 | $ 0.03 | $ 0.02 |
| | | | | |
Non-GAAP basic EPS | | $ 0.35 | $ 0.33 | $ 1.00 | $ 0.92 |
| | | | | |
| | | | | |
Diluted EPS, as reported | | $ 0.29 | $ 0.27 | $ 0.82 | $ 0.76 |
Adjustment to reconcile diluted EPS to non-GAAP | | | | | |
diluted EPS: | | | | | |
Impact of stock-based compensation, net of tax effect | | $ 0.05 | $ 0.04 | $ 0.14 | $ 0.12 |
Impact of amortization of acquisition intangibles, net of tax effect | $ 0.01 | $ 0.01 | $ 0.03 | $ 0.02 |
| | | | | |
Non-GAAP diluted EPS | | $ 0.35 | $ 0.32 | $ 0.99 | $ 0.90 |
| | | | | |
Weighted average shares outstanding - | | | | | |
Basic | | 78,834 | 79,226 | 78,701 | 79,471 |
Diluted | | 79,841 | 80,874 | 79,773 | 80,986 |
| | | | | |
| | | | | |
Reconciliation of GAAP diluted EPS guidance to Non-GAAP diluted EPS for Q4 2008: | |
| | | | | |
| | Q4 2008 | |
| | | | | |
Range of diluted GAAP net earnings per share | | | $0.33 - $0.41 | |
Estimated stock based compensation and amortization of acquired intangibles | $0.06 | | |
| | | | | |
Range of diluted non-GAAP net earnings per share | | | $0.39 - $0.47 | | |
###